LOS ANGELES, Aug. 15, 2014 /PRNewswire/ -- Medbox, Inc. (OTCQB:MDBX) (www.medbox.com) (the "Company"), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, announced today that it has filed its 10-Q for the second quarter ended June 30, 2014, and will host its second quarter 2014 financial results conference call on Monday, August 18, 2014 at 4:15pm EDT.
Guy Marsala, Medbox's CEO, commented, "Our second quarter 2014 results show that our Company is beginning to implement its business model that transitions away from one-time consulting fees, towards a model that generates recurring revenues by partnering and signing management agreements with dispensary and cultivation operators who are committed to operate in a safe, secure and compliant manner. In addition to continuing to build our infrastructure in Medbox Management Services, we are also rolling out a new Medbox Secure Safe, as well as a new portable vaporizer through our wholly owned subsidiary, Vaporfection."
"We believe that these initiatives combined with our pipeline of current business opportunities will create predictable and profitable revenue growth for our Company and build shareholder value for our investors," concluded Mr. Marsala.
This inaugural public company conference call will be hosted by Guy Marsala and Thomas Iwanski, Chief Financial Officer. The live conference call can be accessed by dialing (866) 952-1906. Participants should ask for the Medbox Earnings Conference Call.
Conference Call Details:
Date: Monday, August 18, 2014
Time: 4:15PM EDT
Dial-in Number: (866) 952-1906
The questions and answers part of the conference call will be processed via emailed questions. If you have any questions feel free to submit to [email protected], at least 6 hours prior to the conference call. Please include your name, contact phone number, email address and question.
Participants are recommended to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through September 1, 2014. To listen to the replay, dial (800) 723-6062.
About Medbox, Inc.
Medbox, Inc. ("MDBX" or the "Company") is the leading dispensary infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Headquartered in Los Angeles, CA, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers its patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product. Medbox, through its newly established subsidiaries, is developing the following ancillary services tailored to the alternative medicine industry: merchant services and armored transport for cash deposits, cannabidiol research and development, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and alternative medicine dispensary management services.
The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward looking statement was made.
For more information on Medbox, please call (800) 762-1452.
SOURCE Medbox, Inc.